Valuation: CVRx, Inc.

Market Cap 130M 114M 106M 97.26M 183M 12.5B 186M 1.26B 492M 6.14B 487M 477M 21.24B P/E 2026 *
-2.49x
P/E 2027 * -2.58x
Enterprise Value 155M 136M 127M 116M 219M 14.95B 222M 1.51B 588M 7.35B 583M 570M 25.42B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.6x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day-3.68%
1 week-4.07%
Current month-8.37%
1 month-8.63%
3 months-38.99%
6 months-35.74%
Current year-33.66%
1 week 4.64
Extreme 4.64
5.1
1 month 4.64
Extreme 4.64
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
01/06/26
Treo Ventures LLC
OtherCompany 0 0%
01/06/26 Free

Director

19,902 0.0750%
01/06/26 Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-3.68%-4.07%-42.49%-71.98% 130M
+0.17%+0.15%+38.50%+5.34% 12.5B
+0.52%-0.95%+14.98%+20.01% 6.39B
-0.53%-2.57%+45.33%+20.46% 5.5B
+3.28%-0.89% - - 4.59B
-3.39%-1.19%-29.45%+18.83% 4.47B
-2.85%-4.45%-23.96%-24.19% 4.03B
-9.03%+15.58%+46.73%-52.00% 2.32B
-0.34%-4.23%-12.63%+204.03% 1.71B
+0.33%+0.33%+56.68%-2.86% 1.55B
Average -1.53%+0.42%+10.41%+13.07% 4.32B
Weighted average by Cap. -0.70%+1.01%+19.86%+13.18%

Financials

2026 *2027 *
Net sales 65.28M 57.34M 53.32M 48.93M 91.94M 6.29B 93.36M 633M 247M 3.09B 245M 240M 10.69B 76.18M 66.91M 62.22M 57.1M 107M 7.34B 109M 739M 289M 3.61B 286M 280M 12.47B
Net income -52.82M -46.39M -43.14M -39.59M -74.39M -5.09B -75.53M -512M -200M -2.5B -198M -194M -8.65B -52.14M -45.8M -42.59M -39.08M -73.43M -5.02B -74.56M -506M -198M -2.47B -196M -192M -8.54B
Net Debt 25.51M 22.41M 20.84M 19.12M 35.93M 2.46B 36.48M 247M 96.68M 1.21B 95.77M 93.71M 4.18B 68.44M 60.11M 55.9M 51.3M 96.38M 6.59B 97.87M 664M 259M 3.24B 257M 251M 11.2B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
24/07/26 US$4.720 -3.48% 113,228
23/07/26 US$4.890 -3.93% 187,457
22/07/26 US$5.090 +2.41% 102,768
21/07/26 US$4.970 +4.19% 311,159
20/07/26 US$4.770 -2.85% 347,482
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.890USD
Average target price
11.17USD
Spread / Average Target
+128.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock